Mirabella Financial Services LLP Invests $14.29 Million in The Beauty Health Company (NASDAQ:SKIN)

Mirabella Financial Services LLP bought a new position in shares of The Beauty Health Company (NASDAQ:SKIN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,988,571 shares of the company's stock, valued at approximately $14,292,000. Beauty Health makes up 1.3% of Mirabella Financial Services LLP's investment portfolio, making the stock its 14th biggest holding. Mirabella Financial Services LLP owned 7.24% of Beauty Health as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Barclays PLC lifted its stake in Beauty Health by 11.1% in the 4th quarter. Barclays PLC now owns 117,920 shares of the company's stock valued at $187,000 after acquiring an additional 11,817 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Beauty Health in the fourth quarter valued at approximately $25,000. Renaissance Technologies LLC bought a new stake in shares of Beauty Health in the fourth quarter worth $64,000. Bank of Montreal Can boosted its holdings in Beauty Health by 32.6% during the fourth quarter. Bank of Montreal Can now owns 113,096 shares of the company's stock worth $180,000 after purchasing an additional 27,791 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd bought a new position in Beauty Health in the fourth quarter valued at $57,000. 93.26% of the stock is currently owned by institutional investors and hedge funds.

Beauty Health Stock Up 3.6 %

SKIN traded up $0.03 during trading on Thursday, reaching $0.98. 379,222 shares of the stock were exchanged, compared to its average volume of 1,108,096. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56. The stock's 50 day moving average price is $1.26 and its two-hundred day moving average price is $1.49. The Beauty Health Company has a twelve month low of $0.78 and a twelve month high of $3.63. The stock has a market cap of $122.79 million, a P/E ratio of -2.33 and a beta of 0.84.

Beauty Health (NASDAQ:SKIN - Get Free Report) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.02. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. The company had revenue of $83.50 million for the quarter, compared to analyst estimates of $78.02 million. During the same period in the previous year, the business earned ($0.07) EPS. Equities analysts expect that The Beauty Health Company will post -0.25 EPS for the current year.

Analyst Ratings Changes

Separately, Canaccord Genuity Group cut their price target on shares of Beauty Health from $1.75 to $1.50 and set a "hold" rating on the stock in a research report on Thursday, March 13th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Beauty Health currently has an average rating of "Hold" and a consensus target price of $2.50.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.